ZHAO Lei,GUO Jin-dong,LÜ Chang-xing.Efficacy and Health-Related Quality of Life for small cell lung cancer patients after prophylactic cranial irradiation[J].Chinese Journal of Radiological Medicine and Protection,2013,33(3):294-298
Efficacy and Health-Related Quality of Life for small cell lung cancer patients after prophylactic cranial irradiation
Received:October 01, 2012  
DOI:10.3760/cma.j.issn.0254-5098.2013.03.019
KeyWords:Small cell lung cancer  Prophylactic cranial irradiation  Brain metastasis  Health related quality of life  Therapeutic efficacy
FundProject:
Author NameAffiliationE-mail
ZHAO Lei Department of Radiation Oncology, Shanghai Chest Hospital Affiliated to Shanghai JiaoTong University, Shanghai 200030, China  
GUO Jin-dong Department of Radiation Oncology, Shanghai Chest Hospital Affiliated to Shanghai JiaoTong University, Shanghai 200030, China  
LÜ Chang-xing Department of Radiation Oncology, Shanghai Chest Hospital Affiliated to Shanghai JiaoTong University, Shanghai 200030, China Lvchangxing@citiz.net 
Hits: 3381
Download times: 2462
Abstract::
      Objective To analyze the survival, brain metastases and health-related quality of life(HRQOL) for small cell lung cancer patients after prophylactic cranial irradiation(PCI).Methods From Aug 2007 to Apr 2011, 42 small cell lung cancer patients were eligible for analysis. Overall survival rate was estimated by the Kaplan-Meier method. The HRQOL scores before and after PCI were compared by the nonparameter wilcoxon test.Results The median survival time from the start of PCI was 23 months(95%CI,15.05-30.95),progression free survival time was 17 months (95%CI,14.33-19.67),1-,2- and 3-year survival rates were 85.5%,45.8% and 36.6%, respectively. The median time from PCI to brain metastases was 15 months(95%CI,12.44-17.56),1- and 2-year brain metastases rates were 77.6% and 54.1%. PCI had a little influence on HRQOL scales except for cognitive function.Conclusions For patients with limited stage small cell lung cancer who achieve complete or nearly complete remission after initial treatment as well as patients with extensive stage who respond to initial chemotherapy, PCI is effective in decreasing the rate of brain metastasis and improving survival, while the adverse effects is acceptable. There is no significant impact on HRQOL scales during short term.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:9075788  On-line:0

v
Scan QR Code
&et=8C69D9BCA894EB905C088FE20C788EEA6439FA70B3FD6C91627FE4E70D830767DDE56D35FF2ED926C7D8412A3F0A368E7C833DA3D5ACCFA895F1AF144CFE9A21716896014A80A92CBA2FE1758891B7156928025C8D12157F9A87CF2EC3A19EFDE7E661DE7A75EED288EFD3BE233C94AF1FCBE805BCE26D4D&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=FF7AA908D58E97FA&aid=43201900FF8CF39C46DC36CE37352124&vid=&iid=38B194292C032A66&sid=E39A3F4E3A67639B&eid=88D36036CFF69B3C&fileno=20130319&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="FF7AA908D58E97FA"; var my_aid="43201900FF8CF39C46DC36CE37352124";